MDU, or Medical Device User Fee Amendments, is a regulatory framework in the United States that allows the FDA to collect fees from medical device manufacturers to expedite the review process for new devices. The latest discussions focus on proposed changes to the fee structure and the impact on innovation and patient access to medical technologies.
